Terms: = Bone cancer AND PAX3, MGC120382, 5077, ENSG00000135903, CDHS, MGC120383, HUP2, P23760, WS1, MGC120384, MGC134778, MGC120381 AND Treatment
17 results:
1. Metastatic rhabdomyosarcoma with exclusive distant lymph node involvement: A European Pediatric Soft tissue sarcoma Study Group (EpSSG) report.
Mercolini F; Merks JHM; Minard-Colin V; Cameron A; van Scheltinga SEJT; Sher O; Fichera G; Orbach D; Glosli H; Coppadoro B; Gallego S; Chisholm JC; Bisogno G
Pediatr Blood Cancer; 2023 Mar; 70(3):e30143. PubMed ID: 36519598
[TBL] [Abstract] [Full Text] [Related]
2. Molecular Characterization of Circulating Tumor DNA in Pediatric Rhabdomyosarcoma: A Feasibility Study.
Ruhen O; Lak NSM; Stutterheim J; Danielli SG; Chicard M; Iddir Y; Saint-Charles A; Di Paolo V; Tombolan L; Gatz SA; Aladowicz E; Proszek P; Jamal S; Stankunaite R; Hughes D; Carter P; Izquierdo E; Wasti A; Chisholm JC; George SL; Pace E; Chesler L; Aerts I; Pierron G; Zaidi S; Delattre O; Surdez D; Kelsey A; Hubank M; Bonvini P; Bisogno G; Di Giannatale A; Schleiermacher G; Schäfer BW; Tytgat GAM; Shipley J
JCO Precis Oncol; 2022 Oct; 6():e2100534. PubMed ID: 36265118
[TBL] [Abstract] [Full Text] [Related]
3. Congenital rhabdomyosarcoma: A report from the European paediatric Soft tissue sarcoma Study Group.
Bisogno G; Minard-Colin V; Arush MB; Daragjati J; Coppadoro B; Gallego S; Alaggio R; Smeulders N; Mudry P; Zin A; Merks JHM; Slater O
Pediatr Blood Cancer; 2022 Feb; 69(2):e29376. PubMed ID: 34582098
[TBL] [Abstract] [Full Text] [Related]
4. A Review of the Role of Cytogenetics in the Diagnosis of Orbital Rhabdomyosarcoma.
Cortes Barrantes P; Jakobiec FA; Dryja TP
Semin Ophthalmol; 2019; 34(4):243-251. PubMed ID: 31146616
[TBL] [Abstract] [Full Text] [Related]
5. Early detection of the pax3-FOXO1 fusion gene in circulating tumor-derived DNA in a case of alveolar rhabdomyosarcoma.
Eguchi-Ishimae M; Tezuka M; Kokeguchi T; Nagai K; Moritani K; Yonezawa S; Tauchi H; Tokuda K; Ishida Y; Ishii E; Eguchi M
Genes Chromosomes Cancer; 2019 Aug; 58(8):521-529. PubMed ID: 30739374
[TBL] [Abstract] [Full Text] [Related]
6. Impact of an osteoporosis specialized unit on bone health in breast cancer survivals treated with aromatase inhibitors.
Martínez P; Galve E; Arrazubi V; Sala MÁ; Fernández S; Pérez CE; Arango JF; Torre I
Reumatol Clin (Engl Ed); 2019; 15(4):211-217. PubMed ID: 29032291
[TBL] [Abstract] [Full Text] [Related]
7. Heme Oxygenase-1 Controls an HDAC4-miR-206 Pathway of Oxidative Stress in Rhabdomyosarcoma.
Ciesla M; Marona P; Kozakowska M; Jez M; Seczynska M; Loboda A; Bukowska-Strakova K; Szade A; Walawender M; Kusior M; Stepniewski J; Szade K; Krist B; Yagensky O; Urbanik A; Kazanowska B; Dulak J; Jozkowicz A
Cancer Res; 2016 Oct; 76(19):5707-5718. PubMed ID: 27488535
[TBL] [Abstract] [Full Text] [Related]
8. Results from a Phase I Study of Lapatinib with Gemcitabine and Cisplatin in Advanced or Metastatic Bladder cancer: EORTC Trial 30061.
Cerbone L; Sternberg CN; Sengeløv L; Agerbaek M; Van Herpen C; Marreaud S; Collette S; Zhang J; Daugaard G
Oncology; 2016; 90(1):21-8. PubMed ID: 26468947
[TBL] [Abstract] [Full Text] [Related]
9. Distinct methylation profiles characterize fusion-positive and fusion-negative rhabdomyosarcoma.
Sun W; Chatterjee B; Wang Y; Stevenson HS; Edelman DC; Meltzer PS; Barr FG
Mod Pathol; 2015 Sep; 28(9):1214-24. PubMed ID: 26226845
[TBL] [Abstract] [Full Text] [Related]
10. Molecular Cytogenetics Detect an Unbalanced t(2;13)(q36;q14) and pax3-FOXO1 Fusion in Rhabdomyosarcoma With Mixed Embryonal/Alveolar Features.
La Starza R; Nofrini V; Pierini T; Pierini V; Zin A; Bisogno G; Cerri C; Caniglia M; Sidoni A; Ludwig K; Mecucci C
Pediatr Blood Cancer; 2015 Dec; 62(12):2238-41. PubMed ID: 26179572
[TBL] [Abstract] [Full Text] [Related]
11. Recurrent LRP1-SNRNP25 and KCNMB4-CCND3 fusion genes promote tumor cell motility in human osteosarcoma.
Yang J; Annala M; Ji P; Wang G; Zheng H; Codgell D; Du X; Fang Z; Sun B; Nykter M; Chen K; Zhang W
J Hematol Oncol; 2014 Oct; 7():76. PubMed ID: 25300797
[TBL] [Abstract] [Full Text] [Related]
12. Optimization of rhabdomyosarcoma disseminated disease assessment by flow cytometry.
Almazán-Moga A; Roma J; Molist C; Vidal I; Jubierre L; Soriano A; Segura MF; Llort A; Sánchez de Toledo J; Gallego S
Cytometry A; 2014 Dec; 85(12):1020-9. PubMed ID: 25155056
[TBL] [Abstract] [Full Text] [Related]
13. Cranial metastatic alveolar rhabdomyosarcoma mimicking hematological malignancy in an adolescent boy.
Patiroglu T; Isik B; Unal E; Canoz O; Deniz K; Kosemehmetoglu K; Karakukcu M; Ozdemir MA
Childs Nerv Syst; 2014 Oct; 30(10):1737-41. PubMed ID: 24917491
[TBL] [Abstract] [Full Text] [Related]
14. Alveolar rhabdomyosarcoma after treatment of osteosarcoma.
Kasahara Y; Iwabuchi H; Takachi T; Hosokai R; Yoshida S; Imamura M; Watanabe A; Umezu H; Hotta T; Ogose A; Imai C
Pediatr Int; 2013 Aug; 55(4):527-30. PubMed ID: 23910806
[TBL] [Abstract] [Full Text] [Related]
15. A phase II clinical trial of sorafenib in androgen-independent prostate cancer.
Dahut WL; Scripture C; Posadas E; Jain L; Gulley JL; Arlen PM; Wright JJ; Yu Y; Cao L; Steinberg SM; Aragon-Ching JB; Venitz J; Jones E; Chen CC; Figg WD
Clin Cancer Res; 2008 Jan; 14(1):209-14. PubMed ID: 18172272
[TBL] [Abstract] [Full Text] [Related]
16. A phase 2 study of high-activity 186Re-HEDP with autologous peripheral blood stem cell transplant in progressive hormone-refractory prostate cancer metastatic to bone.
O'Sullivan JM; Norman AR; McCready VR; Flux G; Buffa FM; Johnson B; Coffey J; Cook G; Treleaven J; Horwich A; Huddart RA; Parker CC; Dearnaley DP
Eur J Nucl Med Mol Imaging; 2006 Sep; 33(9):1055-61. PubMed ID: 16572306
[TBL] [Abstract] [Full Text] [Related]
17. Detection of bone marrow micrometastasis and microcirculating disease in rhabdomyosarcoma by a real-time RT-PCR assay.
Gallego S; Llort A; Roma J; Sabado C; Gros L; de Toledo JS
J Cancer Res Clin Oncol; 2006 Jun; 132(6):356-62. PubMed ID: 16435141
[TBL] [Abstract] [Full Text] [Related]
